Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium-activated chloride channels (CaCCs) are a group of ligand-gated ion channels that mediate the flow of chloride ions across cell membranes in response to increases in intracellular calcium levels. These channels play essential roles in various physiological processes, including epithelial secretion, sensory transduction, smooth muscle contraction, neuronal excitability, and fluid homeostasis. TMEM16A (ANO1) and TMEM16B (ANO2) are key members of the TMEM16 (anoctamin) family functioning as CaCCs. They are promising therapeutic targets for conditions characterized by abnormal mucus production or impaired motility, ranging from asthma to cancer.
Channel blockade; Channel activation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium-Activated Chloride Channel Protein.